Literature DB >> 2181719

AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus.

A B Millar1, D M Mitchell.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2181719      PMCID: PMC475653          DOI: 10.1136/thx.45.1.57

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  49 in total

1.  Complement fixation test for pneumocytosis.

Authors:  K Barta
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

2.  Pulmonary involvement in the acquired immunodeficiency syndrome.

Authors:  P C Hopewell; J M Luce
Journal:  Chest       Date:  1985-01       Impact factor: 9.410

3.  Diagnosis of pulmonary disease in acquired immune deficiency syndrome (AIDS). Role of bronchoscopy and bronchoalveolar lavage.

Authors:  D E Stover; D A White; P A Romano; R A Gellene
Journal:  Am Rev Respir Dis       Date:  1984-10

4.  Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.

Authors:  J F Murray; C P Felton; S M Garay; M S Gottlieb; P C Hopewell; D E Stover; A S Teirstein
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

5.  Pneumocystis carinii pneumonia in homosexual men.

Authors:  G Gamsu; S T Hecht; F A Birnberg; D L Coleman; J A Golden
Journal:  AJR Am J Roentgenol       Date:  1982-10       Impact factor: 3.959

6.  Correlation between serial pulmonary function tests and fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome.

Authors:  D L Coleman; P M Dodek; J A Golden; J M Luce; E Golden; W M Gold; J F Murray
Journal:  Am Rev Respir Dis       Date:  1984-03

7.  Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities.

Authors:  E S Overland; A J Nolan; P C Hopewell
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

8.  Correlation between gallium lung scans and fiberoptic bronchoscopy in patients with suspected Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome.

Authors:  D L Coleman; R S Hattner; J M Luce; P M Dodek; J A Golden; J F Murray
Journal:  Am Rev Respir Dis       Date:  1984-12

9.  Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome.

Authors:  L A Engelberg; C W Lerner; M L Tapper
Journal:  Am Rev Respir Dis       Date:  1984-10

10.  Intracellular distribution and radiotoxicity of chromium-51 in mammalian cells: Auger-electron dosimetry.

Authors:  A I Kassis; K S Sastry; S J Adelstein
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more
  5 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

Review 2.  AIDS and the lung. 5--Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus.

Authors:  R F Miller; T R Leigh; J V Collins; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

3.  Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments.

Authors:  R B Nieman; R J Coker; D M Mitchell
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

4.  Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.

Authors:  R B Nieman; J Fleming; R J Coker; J R Harris; D M Mitchell
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

5.  Simplified exercise test for the initial differential diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients.

Authors:  J Sauleda; J Gea; X Aran; M C Aguar; M Orozco-Levi; J M Broquetas
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.